4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-23-043242
Chief Legal Officer sold 6,164 shares at $20.88 ($128,686)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazzariello Gina Chief Legal Officer | 2023-08-15 | Sale 10b5-1 | −6,164 | $20.88 | $128,686 | 49,083 | D |
| Open-market sales · 6,164 sh · avg $20.88 · $128,686 | |||||||
Loading xslF345X05/ownership.xml…